Northrop Grumman Corp. Q1 2026 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2026. Northrop Grumman Corporation is a leading global aerospace and defense technology company, primarily serving the U.S. Department of War (DoW) and intelligence community. The company operates through four segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. Notably, the company completed the divestiture of its Immersive Mission Solutions (IMS) training services business in May 2025; therefore, Q1 2026 results are fully organic compared to Q1 2025, which included IMS sales prior to the sale date.
Key Financial Metrics
| Metric ($ in millions, except per share) | Q1 2026 | Q1 2025 |
|---|---|---|
| Total Sales | $9,881 | $9,468 |
| Operating Income | $989 | $573 |
| Operating Margin | 10.0% | 6.1% |
| Net Earnings | $875 | $481 |
| Diluted EPS | $6.14 | $3.32 |
| Cash and Cash Equivalents | $2,090 | $1,685 |
| Long-Term Debt (net of current) | $14,411 | $15,162 |
| Backlog | $95.6 billion | $95.7 billion (Dec 2025) |
Liquidity: The company maintains a $3.0 billion revolving credit facility and a commercial paper program. As of March 31, 2026, $500 million in commercial paper was outstanding. Net cash used in operating activities was $1.656 billion, consistent with historical seasonal patterns where cash conversion is weighted toward the second half of the year.
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 4% ($413 million) year-over-year. Organic sales grew 5% after adjusting for the prior year's divested training services business.
- Profitability Surge: Operating income increased 73% ($416 million). This was primarily driven by the absence of a $477 million B-21 loss provision recorded in Q1 2025.
- Segment Performance:
- Aeronautics Systems: Sales up 17% and operating income turned from a loss of $183 million to a profit of $305 million, largely due to the absence of the prior year B-21 loss and increased B-21 production volume.
- Mission Systems: Operating income up 20% to $433 million, driven by higher margins and favorable EAC adjustments.
- Space Systems: Sales down 3% and operating income down 17%, impacted by the wind-down of the Next Generation Interceptor (NGI) program and a $71 million unfavorable EAC adjustment on the GEM 63XL program due to a launch anomaly.
- Tax Rate: The effective tax rate decreased to 15.0% from 16.8%, aided by higher research credits and a $19 million benefit from new IRS guidance on the Corporate Alternative Minimum Tax (CAMT).
Guidance, Outlook, and Risks
Management Commentary: Management highlighted a dynamic global security environment driving demand for defense capabilities. The company reached an agreement with the U.S. Air Force to expand B-21 production capacity, expecting to invest approximately $2.5 billion over multiple years. The Sentinel program remains under restructure following a Nunn-McCurdy breach review, with no significant changes to estimated profitability in Q1 2026.
Unusual Items:
- B-21 Program: A $157 million net unfavorable EAC adjustment was recorded on the first four LRIP lots due to higher estimated production costs, partially offset by a reduction in the loss contingency accrual on the remainder of the program. A remaining loss accrual of $1.0 billion is included in current liabilities.
- GEM 63XL: A $71 million unfavorable EAC adjustment was recorded due to a solid rocket motor anomaly during a Q1 2026 launch.
Risks and Contingencies:
- Government Funding: Risks related to U.S. budget priorities, debt ceiling debates, and potential government shutdowns (a partial shutdown was in effect regarding DHS at the time of filing).
- Legal/Regulatory: Ongoing DOJ and DCMA investigations regarding CAS pension expense interest rate assumptions. The company cannot currently estimate the potential loss range but notes it could be material.
- Environmental: Continued remediation costs at the Bethpage, NY site, with accrued costs of $561 million and reasonably possible future costs of $402 million.
Investor Verification Checklist
- B-21 Loss Accrual: Verify the remaining $1.0 billion loss accrual and the impact of the new production rate agreement on future margins.
- Space Systems Anomaly: Assess the long-term financial impact of the GEM 63XL launch failure and corrective actions.
- Government Investigations: Monitor the status of the DOJ/DCMA inquiries into pension accounting assumptions for potential future charges.
- Backlog Conversion: Confirm the $95.6 billion backlog and the expected revenue recognition timeline (35% in next 12 months).
- Share Repurchases: Note the $2.5 billion remaining under the 2024 repurchase program and the reduction in repurchase activity in Q1 2026 compared to Q1 2025.